(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one

Gestoden; LC-ESI-ITFT; MS2; CE: 40%; R=15000; [M+H]+

Gestoden; LC-ESI-ITFT; MS2; CE: 50%; R=15000; [M+H]+

Gestoden; LC-ESI-ITFT; MS2; CE: 60%; R=15000; [M+H]+

Gestoden; LC-ESI-ITFT; MS2; CE: 70%; R=15000; [M+H]+

Gestoden; LC-ESI-ITFT; MS2; CE: 80%; R=15000; [M+H]+

Gestoden; LC-ESI-ITFT; MS2; CE: 90%; R=15000; [M+H]+

Gestoden; LC-ESI-QTOF; MS2; CE: 10 eV; R=35000; [M+H]+

Gestoden; LC-ESI-QTOF; MS2; CE: 20 eV; R=35000; [M+H]+

Gestoden; LC-ESI-QTOF; MS2; CE: 30 eV; R=35000; [M+H]+

Gestoden; LC-ESI-QTOF; MS2; CE: 40 eV; R=35000; [M+H]+

Gestoden; LC-ESI-QTOF; MS2; CE: 50 eV; R=35000; [M+H]+

Gestoden; LC-ESI-QTOF; MS2; CE: Ramp 21.8-32.7 eV; R=35000; [M+H]+